Vaginal Royal Jelly for Vulvovaginal Candidiasis Treatment: A Randomized Clinical Trial
Background: Vulvovaginal Candidiasis (VVC) is a prevalent and complex health issue in women. With the rising resistance to synthetic antifungal medications, there is a growing emphasis on exploring natural remedies that minimize disruption to the normal vaginal flora. The goal of this study is to ev...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-04-01
|
| Series: | Advanced Biomedical Research |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/abr.abr_69_24 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850042286657765376 |
|---|---|
| author | Maryam Ramazany Chaleshtori Mahmoodreza Madadian Azadeh Akbari Sane Farahnaz Farzaneh Vida Kazemi Fatemeh Montazer Susan Sarhadi Maryam Taghavi Shirazi Shahla Mirgaloybayat |
| author_facet | Maryam Ramazany Chaleshtori Mahmoodreza Madadian Azadeh Akbari Sane Farahnaz Farzaneh Vida Kazemi Fatemeh Montazer Susan Sarhadi Maryam Taghavi Shirazi Shahla Mirgaloybayat |
| author_sort | Maryam Ramazany Chaleshtori |
| collection | DOAJ |
| description | Background:
Vulvovaginal Candidiasis (VVC) is a prevalent and complex health issue in women. With the rising resistance to synthetic antifungal medications, there is a growing emphasis on exploring natural remedies that minimize disruption to the normal vaginal flora. The goal of this study is to evaluate the efficacy of vaginal Royal Jelly (RJ) compared with clotrimazole for VVC treatment.
Materials and Methods:
This single-blind randomized clinical trial was conducted from 2020 to 2022 at Iran University of Medical Sciences hospitals, involving a total of 90 patients diagnosed with vaginal candidiasis. Positive vaginal culture individuals were randomly allocated to receive either vaginal 1000 mg RJ soft gel capsules or (2%) Clotrimazole cream (45 participants per group). Clinical signs, symptoms, and laboratory tests were statistically compared at baseline and ten days post-treatment. The data were analyzed using the independent t-tests, Mann-Whitney, Chi-square, and Wilcoxon tests through SPSS version 22.
Results:
After 10 days of treatment, both groups demonstrated a significant decrease in Candida culture results (P < 0.001). RJ also positively impacted vaginal symptoms such as itching, discharge, and burning. Moreover, most patients in both groups became asymptomatic post-treatment.
Conclusions:
The present study points out the therapeutic effects of vaginal RJ, a novel natural drug for improving VVC. |
| format | Article |
| id | doaj-art-f11a1c47be564b3daa71764a04395c8c |
| institution | DOAJ |
| issn | 2277-9175 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Advanced Biomedical Research |
| spelling | doaj-art-f11a1c47be564b3daa71764a04395c8c2025-08-20T02:55:36ZengWolters Kluwer Medknow PublicationsAdvanced Biomedical Research2277-91752025-04-01141323210.4103/abr.abr_69_24Vaginal Royal Jelly for Vulvovaginal Candidiasis Treatment: A Randomized Clinical TrialMaryam Ramazany ChaleshtoriMahmoodreza MadadianAzadeh Akbari SaneFarahnaz FarzanehVida KazemiFatemeh MontazerSusan SarhadiMaryam Taghavi ShiraziShahla MirgaloybayatBackground: Vulvovaginal Candidiasis (VVC) is a prevalent and complex health issue in women. With the rising resistance to synthetic antifungal medications, there is a growing emphasis on exploring natural remedies that minimize disruption to the normal vaginal flora. The goal of this study is to evaluate the efficacy of vaginal Royal Jelly (RJ) compared with clotrimazole for VVC treatment. Materials and Methods: This single-blind randomized clinical trial was conducted from 2020 to 2022 at Iran University of Medical Sciences hospitals, involving a total of 90 patients diagnosed with vaginal candidiasis. Positive vaginal culture individuals were randomly allocated to receive either vaginal 1000 mg RJ soft gel capsules or (2%) Clotrimazole cream (45 participants per group). Clinical signs, symptoms, and laboratory tests were statistically compared at baseline and ten days post-treatment. The data were analyzed using the independent t-tests, Mann-Whitney, Chi-square, and Wilcoxon tests through SPSS version 22. Results: After 10 days of treatment, both groups demonstrated a significant decrease in Candida culture results (P < 0.001). RJ also positively impacted vaginal symptoms such as itching, discharge, and burning. Moreover, most patients in both groups became asymptomatic post-treatment. Conclusions: The present study points out the therapeutic effects of vaginal RJ, a novel natural drug for improving VVC.https://journals.lww.com/10.4103/abr.abr_69_24clotrimazoleroyal jellyvulvovaginal candidiasis |
| spellingShingle | Maryam Ramazany Chaleshtori Mahmoodreza Madadian Azadeh Akbari Sane Farahnaz Farzaneh Vida Kazemi Fatemeh Montazer Susan Sarhadi Maryam Taghavi Shirazi Shahla Mirgaloybayat Vaginal Royal Jelly for Vulvovaginal Candidiasis Treatment: A Randomized Clinical Trial Advanced Biomedical Research clotrimazole royal jelly vulvovaginal candidiasis |
| title | Vaginal Royal Jelly for Vulvovaginal Candidiasis Treatment: A Randomized Clinical Trial |
| title_full | Vaginal Royal Jelly for Vulvovaginal Candidiasis Treatment: A Randomized Clinical Trial |
| title_fullStr | Vaginal Royal Jelly for Vulvovaginal Candidiasis Treatment: A Randomized Clinical Trial |
| title_full_unstemmed | Vaginal Royal Jelly for Vulvovaginal Candidiasis Treatment: A Randomized Clinical Trial |
| title_short | Vaginal Royal Jelly for Vulvovaginal Candidiasis Treatment: A Randomized Clinical Trial |
| title_sort | vaginal royal jelly for vulvovaginal candidiasis treatment a randomized clinical trial |
| topic | clotrimazole royal jelly vulvovaginal candidiasis |
| url | https://journals.lww.com/10.4103/abr.abr_69_24 |
| work_keys_str_mv | AT maryamramazanychaleshtori vaginalroyaljellyforvulvovaginalcandidiasistreatmentarandomizedclinicaltrial AT mahmoodrezamadadian vaginalroyaljellyforvulvovaginalcandidiasistreatmentarandomizedclinicaltrial AT azadehakbarisane vaginalroyaljellyforvulvovaginalcandidiasistreatmentarandomizedclinicaltrial AT farahnazfarzaneh vaginalroyaljellyforvulvovaginalcandidiasistreatmentarandomizedclinicaltrial AT vidakazemi vaginalroyaljellyforvulvovaginalcandidiasistreatmentarandomizedclinicaltrial AT fatemehmontazer vaginalroyaljellyforvulvovaginalcandidiasistreatmentarandomizedclinicaltrial AT susansarhadi vaginalroyaljellyforvulvovaginalcandidiasistreatmentarandomizedclinicaltrial AT maryamtaghavishirazi vaginalroyaljellyforvulvovaginalcandidiasistreatmentarandomizedclinicaltrial AT shahlamirgaloybayat vaginalroyaljellyforvulvovaginalcandidiasistreatmentarandomizedclinicaltrial |